Related by context. Frequent words. (Click for all words.) 66 Clarus Ventures 66 5AM Ventures 66 OrbiMed Advisors 65 HealthCare Ventures 65 Novartis Venture 64 Bayhill Therapeutics 64 Oxford Bioscience 64 Prospect Venture Partners 64 Arboretum Ventures 64 Versant Ventures 63 Forbion Capital Partners 63 InnovationsKapital 63 Sofinnova Ventures 63 Quark Pharmaceuticals 63 Stata Venture Partners 62 Aisling Capital 62 Ampersand Ventures 62 ProQuest Investments 62 MedImmune Ventures 62 Sanderling Ventures 62 TVM Capital 61 HLM Venture Partners 61 FluoroPharma 61 Sofinnova Partners 61 OncoMed Pharmaceuticals 60 Peptimmune 60 MPM Capital 60 Vivo Ventures 60 Karolinska Development 60 AGF Private Equity 60 PTV Sciences 60 PsychoGenics 60 Abingworth 60 Giza Venture 60 NGEN Partners 60 Agios Pharmaceuticals 60 Domain Associates 60 Regado Biosciences 59 SVLS 59 Gimv 59 www.vivus.com 59 Aerovance 59 ARCH Venture Partners 59 Files Shelf Registration Statement 59 PregLem 59 Ventech 58 Pappas Ventures 58 Initiates Phase II 58 Diatos 58 Therapeutic Competitors 58 Eyetech Pharmaceuticals 58 InterWest Partners 58 DFJ Esprit 58 Truffle Capital 58 AFFiRiS 58 Trophos 57 Inc Therapeutic Competitors 57 WRF Capital 57 Presents Positive 57 TargeGen 57 OrbiMed 57 Boehringer Mannheim 57 Bayer HealthCare subsidiary 57 Alloy Ventures 57 Pitango Venture Capital 57 Leaf Venture Partners 57 LinkMed 57 CVRx 57 Prism Venture Partners 57 Evolva 57 Receives Orphan Drug Designation 57 AXYS Design Automation 57 Physic Ventures 57 Metalmark Capital 57 Regulus Therapeutics 57 Baird Venture Partners 57 AGTC 57 Aposense 57 Advent Venture Partners 56 Idera Pharmaceuticals 56 DSM Venturing 56 HepaLife Technologies Inc. 56 Molecular Biometrics 56 Welcomes Analyst Initiation 56 AviaraDx 56 Tudor Ventures 56 Onset Ventures 56 Venrock Associates 56 Galenea 56 Prof. Pnina Fishman 56 Relypsa 56 Tallwood Venture Capital 56 Pervasis 56 NovImmune 56 GTCR Golder Rauner LLC 56 Acologix 56 Quaker BioVentures 55 Pressure BioSciences 55 Sachiko Kuno Ph.D. 55 Cerimon 55 Tenaya Capital